MYC and prostate carcinoma: To determine whether c-Myc facilitated prostatic cancer drugs resistance through a multidrug resistant protein associated manner, we overexpressed c-Myc in LNCaP/VCaP cells (Fig. 4A) and examined the expression of major ABC transporters using q-PCR.